Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Assessing risk of neurodevelopmental disorders after birth with oxytocin: a systematic review and meta-analysis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Startle habituation, sensory, and sensorimotor gating in trauma-affected refugees with posttraumatic stress disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Experts have raised concerns that oxytocin for labor induction and augmentation may have detrimental effects on the neurodevelopment of children. To investigate whether there is the reason for concern, we reviewed and evaluated the available evidence by searching databases with no language or date restrictions up to 9 September 2018. We included English-language studies reporting results on the association between perinatal oxytocin exposure and any cognitive impairment, psychiatric symptoms or disorders in childhood. We assessed the quality of studies using the Newcastle-Ottawa Quality Assessment Scales. Independent risk estimates were pooled using random-effects meta-analyses when at least two independent datasets provided data on the same symptom or disorder. Otherwise, we provided narrative summaries. Two studies examined cognitive impairment, one examined problem behavior, three examined attention-deficit/hyperactivity disorder (ADHD) and seven focused on autism spectrum disorders (ASD). We provided narrative summaries of the studies on cognitive impairment. For ADHD, the pooled risk estimate was 1.17; 95% confidence interval (CI) 0.77-1.78, based on a pooled sample size of 5 47 278 offspring. For ASD, the pooled risk estimate was 1.10; 95% CI 1.04-1.17, based on 8 87 470 offspring. Conclusions that perinatal oxytocin increases the risks of neurodevelopmental problems are premature. Observational studies of low to high quality comprise the evidence-base, and confounding, especially by the genetic or environmental vulnerability, remains an issue. Current evidence is insufficient to justify modifying obstetric guidelines for the use of oxytocin, which state that it should only be used when clinically indicated.

Original languageEnglish
JournalPsychological Medicine
Number of pages10
ISSN0033-2917
DOIs
Publication statusPublished - 1 Apr 2019

ID: 55819932